ASLAN Pharmaceuticals Limited logo
ASLAN Pharmaceuticals Limited ASLN

Geschäftsbericht 2020
hinzugefügt 19.08.2023

report update icon

ASLAN Pharmaceuticals Limited Langfristiger Schuldenstrom 2011-2026 | ASLN

Langfristiger Schuldenstrom Jährlich ASLAN Pharmaceuticals Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 272 K 265 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
272 K 265 K 268 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.64 -1.89 % $ 1.09 B canadaCanada
ADMA Biologics ADMA Biologics
ADMA
1.1 M $ 16.45 0.43 % $ 3.92 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.8 M $ 76.75 0.85 % $ 1.48 B usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
7.09 M $ 19.93 -1.14 % $ 2.51 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.83 4.23 % $ 4.53 M chinaChina
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
11 K - - $ 521 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
549 K - -2.5 % $ 5.88 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
434 K $ 163.82 -0.14 % $ 8.15 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
6.19 M $ 66.98 3.8 % $ 12.8 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
137 K - -16.75 % $ 25.8 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
522 K $ 2.88 2.51 % $ 908 M israelIsrael
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
8.57 M $ 60.75 3.79 % $ 11.7 B usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
781 K - - $ 1.2 B usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.5 M - - $ 2.18 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Cabaletta Bio Cabaletta Bio
CABA
3.56 M $ 3.41 4.77 % $ 3.98 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
749 K $ 25.71 -0.5 % $ 688 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Codexis Codexis
CDXS
2.83 M $ 1.1 12.24 % $ 80.7 M usaUSA
Certara Certara
CERT
3.92 M $ 7.33 1.24 % $ 1.18 B usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
704 K - - $ 105 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
97 K - 7.55 % $ 38.1 M usaUSA